Skip to main content
Fig. 2 | Radiation Oncology

Fig. 2

From: The prognostic significance of pretreatment squamous cell carcinoma antigen levels in cervical cancer patients treated by concurrent chemoradiation therapy and a comparison of dosimetric outcomes and clinical toxicities between tomotherapy and volumetric modulated arc therapy

Fig. 2

The Kaplan–Meier survival curve of progression-free survival. Progression-free survival correlated with a overall treatment time of radiation therapy b T classification c N classification d pretreatment serum squamous cell carcinoma antigen (SCC Ag), and e post-treatment serum SCC Ag

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us